- Home
- TEVA vs VMC Comparison
TEVA vs VMC Comparison
Compare TEVA & VMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TEVA | VMC |
|---|---|---|
| Founded | 1901 | 1909 |
| Country | Israel | United States |
| Employees | 32842 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9B | 36.2B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | TEVA | VMC |
|---|---|---|
| Price | $32.98 | $300.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $38.63 | ★ $323.17 |
| AVG Volume (30 Days) | ★ 4.7M | 1.2M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | ★ 18.39 |
| EPS | N/A | ★ 1.26 |
| Revenue | N/A | ★ $7,781,900,000.00 |
| Revenue This Year | N/A | $1.85 |
| Revenue Next Year | $2.97 | $6.22 |
| P/E Ratio | ★ $28.19 | $232.53 |
| Revenue Growth | N/A | ★ 6.38 |
| 52 Week Low | $14.99 | $252.35 |
| 52 Week High | $37.35 | $331.09 |
Technical Indicators
Market Signals| Indicator | TEVA | VMC |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 64.75 |
| Support Level | $30.53 | $292.44 |
| Resistance Level | $35.37 | $313.36 |
| Average True Range (ATR) | 1.15 | 8.17 |
| MACD | -0.14 | 2.71 |
| Stochastic Oscillator | 18.99 | 95.68 |
Price Performance
Historical ComparisonAbout TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
About VMC Vulcan Materials Company (Holding Company)
Vulcan Materials is the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). Its largest markets include Texas, California, Virginia, Tennessee, Georgia, Florida, North Carolina, and Alabama. In 2024, Vulcan sold 219.9 million tons of aggregates, 13.6 million tons of asphalt mix, and 3.6 million cubic yards of ready-mix. As of Dec. 31, 2024, the company had 16.5 billion tons of aggregate reserves.